The microbiome company—Unlocking Nature's full potential
Unculturable microbes • probiotics • disruptive technology platform
Culture and screen up to 30 million strains in a single day
BIOMILLENIA develops microbial strains and discovers new strains with desired properties from previously unculturable microbiomes.
Our disruptive development platform, based on licensed technology that was developed by Harvard University, the BROAD Institute and ESPCI Paris, uniquely combines single-cell culture and advanced assay development with microfluidics-based ultrahigh-throughput screening.
BIOMILLENIA revolutionises the development of non-GMO strains and microbial products based on this unprecedented throughput in culture and analysis of microbial strains as is desired for e.g. the food market. We “Unlock Nature’s Potential” with novel microbes and natural ingredients for better living.
-
Services
Get access to Biomillenia’s disruptive technology platform in our services department. Our customers obtain improved R&D and product development capabilities by getting better results at higher speed and lower costs.
Outsource your screening and development activities today to improve your microbial strains or enzymes in a fee-for-service project.
-
Partnering
We jointly develop novel microbial products and strains to increase our partner’s competitiveness and profitability by product innovation. Products, formerly difficult to conceive with traditional methods, drive your innovation engine with a limited financial engagement through reduced R&D costs.
Contact us today to find out more.
-
New markets
We create new market segments with high growth potential, thanks to our unique capabilities for non-GMO microbial strain development and discovery of novel strains from microbiomes.
We unlock Nature’s Potential with novel microbes and natural ingredients for better living.
Technology
Disruptive technology for microbiome-based products
Droplet-based microfluidics revolutionises microbiome discovery and product development. Million-fold smaller volumes, magnitudes higher speed, and versatile assay technologies. We leave today’s limits of high-throughput automation behind.
Disruptive innovator in microbiome product development
We unlock unculturable microbiomes
No throughput limitation—culture and test millions of strains in parallel
From single cell to insight
Partnered programs
Ally with us to deliver your breakthroughs
Increase your competitiveness and profitability by product innovation. Products, formerly difficult to conceive with traditional methods, drive your innovation engine with a limited financial engagement through reduced R&D costs.
Services
Delivering results for you
Access Biomillenia’s disruptive technology platform in our services department. Our customers obtain improved R&D and product development capabilities by getting better results at higher speed and lower costs.
Directed enzyme evolution
Metabolic engineering
Strain improvement
Compound screening
Broad assay range
News
Discover latest news and information about Biomillenia. Find out about events where you can meet us.